JP5892933B2 - ガスミスト吸入器 - Google Patents
ガスミスト吸入器 Download PDFInfo
- Publication number
- JP5892933B2 JP5892933B2 JP2012522662A JP2012522662A JP5892933B2 JP 5892933 B2 JP5892933 B2 JP 5892933B2 JP 2012522662 A JP2012522662 A JP 2012522662A JP 2012522662 A JP2012522662 A JP 2012522662A JP 5892933 B2 JP5892933 B2 JP 5892933B2
- Authority
- JP
- Japan
- Prior art keywords
- gas
- gas mist
- mist
- liquid
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003595 mist Substances 0.000 title claims description 169
- 239000007789 gas Substances 0.000 claims description 319
- 239000007788 liquid Substances 0.000 claims description 73
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 44
- 239000001569 carbon dioxide Substances 0.000 claims description 22
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 22
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- 239000001301 oxygen Substances 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 21
- 238000010521 absorption reaction Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 claims description 6
- 239000011941 photocatalyst Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 206010022000 influenza Diseases 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 3
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 3
- 241000241413 Propolis Species 0.000 claims description 3
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 230000003444 anaesthetic effect Effects 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 3
- 239000000043 antiallergic agent Substances 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 239000003429 antifungal agent Substances 0.000 claims description 3
- 239000002220 antihypertensive agent Substances 0.000 claims description 3
- 229940030600 antihypertensive agent Drugs 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 229910052586 apatite Inorganic materials 0.000 claims description 3
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 3
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims description 3
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 3
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 230000003779 hair growth Effects 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 229960003971 influenza vaccine Drugs 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 229940041616 menthol Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 229940069949 propolis Drugs 0.000 claims description 3
- 229960003471 retinol Drugs 0.000 claims description 3
- 235000020944 retinol Nutrition 0.000 claims description 3
- 239000011607 retinol Substances 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 3
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 claims description 3
- 235000018341 sodium sesquicarbonate Nutrition 0.000 claims description 3
- 150000003431 steroids Chemical class 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 150000003700 vitamin C derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- -1 anesthetic Chemical compound 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 229960004756 ethanol Drugs 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 239000003907 antipyretic analgesic agent Substances 0.000 claims 1
- 230000009471 action Effects 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 229940035676 analgesics Drugs 0.000 description 3
- 239000000730 antalgic agent Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical compound ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000026844 throat symptom Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0666—Nasal cannulas or tubing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8218—Gas operated
- A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/84—General characteristics of the apparatus for treating several patients simultaneously
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Devices For Medical Bathing And Washing (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Medicinal Preparation (AREA)
Description
図1は、本発明の第1の実施形態に係るガスミスト吸入器の全体概略図である。
上記第1の実施形態では、ガス供給手段として小型のカートリッジ式ガスボンベ110を用いる例を示したが、本実施形態では、据置型のガス供給装置を用いる例について示す。
上記第2の実施形態では、一つのガスミスト生成器120に対して一つの吸入部材を接続する例を示したが、本実施形態では、複数の吸入部材を接続する構成について説明する。
110 ガスボンベ
120 ガスミスト生成器
121 生成器本体
122 液体貯留部
122A 遮蔽板
123 ノズル
123A ノズル先端開口
124 吸液管形成部材
124A 吸液管
124B 吸液管先端部
125 バッフル
126 ガスボンベ接続部
126A ダイヤルスイッチ
126B 残量ゲージ
127 通気孔
128 中間部材
129 ガス供給部
131 ガス導入部
132 ガスミスト収集部
133 蓋部材
134 ガスミスト導出部
135 ガスミスト排出口
136 ガスミスト供給管
136A ジャバラ状の管
137 ガスミスト供給管
140 吸入マスク
140A 口用マスク
140B 鼻用マスク
141、141A、141B 接続部
142、142A、142B 吸入口
150 ガス供給装置
151 電源スイッチ
152 酸素供給ON/OFFスイッチ
153 炭酸ガス供給ON/OFFスイッチ
154 ガス混合比設定部
155 OFFタイマー
156 ガス供給圧調整部
157 ガス供給管
160 複数の吸入部材
160A、160B、160C 吸入部材
Claims (12)
- 酸素、炭酸ガス、又は酸素と炭酸ガスの混合ガス(以下、「ガス」という)を供給するガス供給手段と、
前記ガス供給手段と接続されると共に、液体を貯留する液体貯留部と、前記液体貯留部の内部を上下で遮閉して液体を貯留している下方部分の圧力が上方部分の圧力よりも高くなるように維持する遮蔽板と、前記ガスを加圧供給するノズルと、前記ノズルの先端に前記液体を送液する吸液管と、前記ノズルの先端に対向して配置されるバッフルと、前記ノズルの先端開口と前記吸液管の先端部と前記バッフルとを覆うように延出する上下方向に配置された管状孔であるガス導入部と、外気を取り込むための通気孔と、を有し、前記液体と前記ガスとを前記バッフルに衝突させてミスト(以下、「ガスミスト」という)を生成するガスミスト生成手段と、
前記ガスミスト生成手段に接続されて前記ガスミストを生体に吸入させるための吸入口を有する吸入部材と、を備え、
前記ガスミスト生成手段がさらに、前記ノズルとは別途に、前記ガス導入部の上方から前記ノズルに向けて前記ガス供給手段からの前記ガスを供給するガス導入手段を設けて、前記吸入部材へのガスミストの供給圧を上げるようにしたことを特徴とするガスミスト吸入器。 - 前記吸入部材が、外気を取り込むための開口をさらに有することを特徴とする請求項1に記載のガスミスト吸入器。
- 前記ガス供給手段が、カートリッジ式ガスボンベであることを特徴とする請求項1又は2に記載のガスミスト吸入器。
- 前記ガス供給手段が、ガス供給時間設定部、ガス供給圧調整部、ガス混合比設定部の何れか一つ又は複数を備えることを特徴とする請求項1乃至3の何れかの項に記載のガスミスト吸入器。
- 前記ガスミスト生成手段が、複数の前記吸入部材にガスミストを供給することを特徴とする請求項1乃至4の何れかの項に記載のガスミスト吸入器。
- 前記液体は、水、イオン水、オゾン水、生理食塩水、精製水、又は滅菌精製水の何れか一つ又は複数の組み合わせであることを特徴とする請求項1に記載のガスミスト吸入器。
- 前記液体は、メンソール、ビタミンE、ビタミンC誘導体、レチノール、麻酔薬、シクロデキストリン、光触媒、光触媒とアパタイトの複合体、ヒアルロン酸、コエンザイムQ10、シードオイル、プロポリス、エタノール、グルコン酸クロルヘキシジン、両性界面活性剤、塩化ベンザルコニウム、酢酸アルキルジアミノエテルグリシン、次亜塩素酸ナトリウム、過酢酸、セスキ炭酸ナトリウム、シリカ、ポピドンヨード、炭酸水素ナトリウム、高濃度炭酸泉剤、抗アレルギー剤、抗炎症剤、解熱鎮痛剤、抗真菌剤、抗インフルエンザウィルス剤、インフルエンザワクチン、ステロイド剤、抗ガン剤、血圧降下剤、化粧剤、増毛剤、発毛剤、又は育毛剤のうち、何れか一つ又は複数をさらに含有することを特徴とする請求項6に記載のガスミスト吸入器。
- 前記ガスミスト生成手段から前記吸入部材内に供給される前記ミストの粒径が、10μm以下であることを特徴とする請求項1に記載のガスミスト吸入器。
- 前記ガスミスト生成手段が、前記吸入部材へガスミストを供給するためのガスミスト供給管を有し、
該ガスミスト供給管が、管内に付着する液滴を除去するためのフィルターを備えることを特徴とする請求項1に記載のガスミスト吸入器。 - 前記ガスミスト生成手段が、前記吸入部材へガスミストを供給するためのガスミスト供給管を有し、
該ガスミスト供給管の全部又は一部がジャバラ状の管から構成されることを特徴とする請求項1に記載のガスミスト吸入器。 - 前記ガスミスト生成手段が、前記吸入部材へガスミストを供給するためのガスミスト供給管を有し、
該ガスミスト供給管に、逆止弁を設けることを特徴とする請求項1に記載のガスミスト吸入器。 - 前記ガスミスト生成手段が、予め滅菌処理されていることを特徴とする請求項1に記載のガスミスト吸入器。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012522662A JP5892933B2 (ja) | 2010-07-01 | 2011-06-29 | ガスミスト吸入器 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010150848 | 2010-07-01 | ||
JP2010150848 | 2010-07-01 | ||
PCT/JP2011/064910 WO2012002433A1 (ja) | 2010-07-01 | 2011-06-29 | ガスミスト吸入器 |
JP2012522662A JP5892933B2 (ja) | 2010-07-01 | 2011-06-29 | ガスミスト吸入器 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2012002433A1 JPWO2012002433A1 (ja) | 2013-08-29 |
JP5892933B2 true JP5892933B2 (ja) | 2016-03-23 |
Family
ID=45402138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012522662A Expired - Fee Related JP5892933B2 (ja) | 2010-07-01 | 2011-06-29 | ガスミスト吸入器 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20120279498A1 (ja) |
EP (1) | EP2500054A4 (ja) |
JP (1) | JP5892933B2 (ja) |
CN (1) | CN102665808B (ja) |
WO (1) | WO2012002433A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9919939B2 (en) | 2011-12-06 | 2018-03-20 | Delta Faucet Company | Ozone distribution in a faucet |
CN103800979B (zh) * | 2013-06-19 | 2018-05-04 | 林信涌 | 保健气体产生器 |
GB2519970B (en) * | 2013-11-01 | 2017-06-14 | Consort Medical Plc | Medicament delivery device sub-assembly |
WO2016029353A1 (zh) * | 2014-08-26 | 2016-03-03 | 得高健康家居有限公司上海分公司 | 一种新型反流式供氧装置 |
US11458214B2 (en) | 2015-12-21 | 2022-10-04 | Delta Faucet Company | Fluid delivery system including a disinfectant device |
JP2018130224A (ja) * | 2017-02-14 | 2018-08-23 | 株式会社フェザーグラス | 吸入装置 |
CN106902426A (zh) * | 2017-04-17 | 2017-06-30 | 苏州雾联医疗科技有限公司 | 一种可调式雾化器 |
US11529492B2 (en) | 2017-06-28 | 2022-12-20 | Mayo Foundation For Medical Education And Research | Methods and materials for treating hypocapnia |
CN110942561B (zh) * | 2019-04-11 | 2021-08-06 | 重庆科斯特医疗科技有限公司 | 一种雾化共享平台 |
AU2020281583A1 (en) | 2019-05-24 | 2021-12-23 | Boehringer Ingelheim Vetmedica Gmbh | Inhalers as well as protective device and breath indicator |
CN110585535B (zh) * | 2019-08-22 | 2022-10-28 | 北京吉纳高新医疗器械有限公司 | 鼻疗雾化器 |
WO2022032468A1 (zh) * | 2020-08-11 | 2022-02-17 | 黄志祥 | 抗呼吸道病毒的装置、方法及药物 |
WO2024129899A2 (en) * | 2022-12-13 | 2024-06-20 | Mayo Foundation For Medical Education And Research | Methods and materials for treating hypocapnia |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3603308A (en) * | 1968-07-15 | 1971-09-07 | Air Reduction | Intermittent positive pressure breathing device |
JPS4911196B1 (ja) * | 1969-08-22 | 1974-03-15 | ||
US4392490A (en) * | 1981-02-23 | 1983-07-12 | Mattingly Glen R | Multiple outlet connecting means for self-contained positive pressure or demand regulated breathing apparatus |
JPS6346154U (ja) * | 1986-09-16 | 1988-03-29 | ||
US5054478A (en) * | 1989-04-21 | 1991-10-08 | Trudell Medical | Nebulizer |
JPH09103488A (ja) * | 1995-06-06 | 1997-04-22 | Medanz Starnberg Gmbh Med Techn Gerate | 流体霧化装置 |
US6340023B2 (en) * | 2000-05-17 | 2002-01-22 | John I. Elkins | Rebreather nebulizer device |
JP2006263235A (ja) * | 2005-03-24 | 2006-10-05 | Major Tsushin:Kk | 定量噴出装置 |
US20070227535A1 (en) * | 2006-03-30 | 2007-10-04 | Harrington Steven M | Nebulizer with flow-based fluidic control and related methods |
JP2008220661A (ja) * | 2007-03-13 | 2008-09-25 | Omron Healthcare Co Ltd | ネブライザ用吸入補助具およびネブライザ用中継管ならびにネブライザ用マスク |
WO2010064643A1 (ja) * | 2008-12-04 | 2010-06-10 | 日本エー・シー・ピー株式会社 | ガスミスト圧浴システム |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3713440A (en) * | 1971-01-18 | 1973-01-30 | P Nicholes | Filtration system |
US4886055A (en) * | 1988-01-22 | 1989-12-12 | Hoppough John M | Nebulizer device |
US4938209A (en) * | 1989-01-12 | 1990-07-03 | Fry William J | Mask for a nebulizer |
US5020530A (en) * | 1990-05-07 | 1991-06-04 | Miller Warren C | Inhalation therapy device |
US5318015A (en) * | 1992-09-03 | 1994-06-07 | Sven Mansson | Inhaler having ejector structure that provides primary and secondary atomization of an actuated dose of medicament |
US5584285A (en) * | 1995-06-07 | 1996-12-17 | Salter Labs | Breathing circuit apparatus for a nebulizer |
US5586551A (en) * | 1995-07-17 | 1996-12-24 | Hilliard; Kenneth R. | Oxygen mask with nebulizer |
GB2334686B (en) * | 1998-02-26 | 2002-06-19 | Medic Aid Ltd | Nebuliser |
US6412481B1 (en) * | 1999-12-23 | 2002-07-02 | Robert Bienvenu | Sealed backpressure attachment device for nebulizer |
DE10239321B3 (de) * | 2002-08-27 | 2004-04-08 | Pari GmbH Spezialisten für effektive Inhalation | Aerosoltherapievorrichtung |
US8181650B2 (en) * | 2003-05-15 | 2012-05-22 | Robert Fayette Andrew Nelson | Multitask medical treatment respiratory apparatus |
US7836884B2 (en) * | 2004-07-06 | 2010-11-23 | Wright Vivian A | Face and tracheostomy nebulizing mask |
EP1807136A2 (en) * | 2004-10-12 | 2007-07-18 | Aradigm Corporation | Device and method for generating an aerosol from a liquid formulation and ensuring its sterility |
US20070074722A1 (en) * | 2005-09-21 | 2007-04-05 | Kurve Technology, Inc. | Medicament delivery control, monitoring, and reporting system and method |
JP4765526B2 (ja) * | 2005-10-04 | 2011-09-07 | オムロンヘルスケア株式会社 | 吸入器および吸入器用マウスピース |
US7669595B1 (en) * | 2006-04-03 | 2010-03-02 | Mitchell Bryon L | Junction device |
US7905229B2 (en) * | 2006-08-30 | 2011-03-15 | Kurve Technology, Inc. | Aerosol generating and delivery device |
US8051854B2 (en) * | 2006-09-15 | 2011-11-08 | Comedica Incorporated | Continuous high-frequency oscillation breathing treatment apparatus |
JP5092820B2 (ja) * | 2008-03-13 | 2012-12-05 | オムロンヘルスケア株式会社 | ネブライザおよびこれに用いられる吸入補助具 |
CN102196839A (zh) * | 2008-08-29 | 2011-09-21 | 株式会社福岛O-Two | 氧供给装置 |
US8875698B2 (en) * | 2009-02-26 | 2014-11-04 | Acp Japan | Gas mist inhaler |
WO2010137493A1 (ja) * | 2009-05-29 | 2010-12-02 | 日本エー・シー・ピー株式会社 | ガスミスト吸入器 |
-
2011
- 2011-06-29 JP JP2012522662A patent/JP5892933B2/ja not_active Expired - Fee Related
- 2011-06-29 CN CN201180004659.9A patent/CN102665808B/zh not_active Expired - Fee Related
- 2011-06-29 EP EP11800895.2A patent/EP2500054A4/en not_active Withdrawn
- 2011-06-29 US US13/515,182 patent/US20120279498A1/en not_active Abandoned
- 2011-06-29 WO PCT/JP2011/064910 patent/WO2012002433A1/ja active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3603308A (en) * | 1968-07-15 | 1971-09-07 | Air Reduction | Intermittent positive pressure breathing device |
JPS4911196B1 (ja) * | 1969-08-22 | 1974-03-15 | ||
US4392490A (en) * | 1981-02-23 | 1983-07-12 | Mattingly Glen R | Multiple outlet connecting means for self-contained positive pressure or demand regulated breathing apparatus |
JPS6346154U (ja) * | 1986-09-16 | 1988-03-29 | ||
US5054478A (en) * | 1989-04-21 | 1991-10-08 | Trudell Medical | Nebulizer |
JPH09103488A (ja) * | 1995-06-06 | 1997-04-22 | Medanz Starnberg Gmbh Med Techn Gerate | 流体霧化装置 |
US6340023B2 (en) * | 2000-05-17 | 2002-01-22 | John I. Elkins | Rebreather nebulizer device |
JP2006263235A (ja) * | 2005-03-24 | 2006-10-05 | Major Tsushin:Kk | 定量噴出装置 |
US20070227535A1 (en) * | 2006-03-30 | 2007-10-04 | Harrington Steven M | Nebulizer with flow-based fluidic control and related methods |
JP2008220661A (ja) * | 2007-03-13 | 2008-09-25 | Omron Healthcare Co Ltd | ネブライザ用吸入補助具およびネブライザ用中継管ならびにネブライザ用マスク |
WO2010064643A1 (ja) * | 2008-12-04 | 2010-06-10 | 日本エー・シー・ピー株式会社 | ガスミスト圧浴システム |
Also Published As
Publication number | Publication date |
---|---|
CN102665808A (zh) | 2012-09-12 |
JPWO2012002433A1 (ja) | 2013-08-29 |
EP2500054A4 (en) | 2014-10-08 |
CN102665808B (zh) | 2016-03-16 |
WO2012002433A1 (ja) | 2012-01-05 |
EP2500054A1 (en) | 2012-09-19 |
US20120279498A1 (en) | 2012-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5892933B2 (ja) | ガスミスト吸入器 | |
JP5674637B2 (ja) | ガスミスト吸入器 | |
JP5102376B2 (ja) | ガスミスト吸入器 | |
JP5475765B2 (ja) | ガスミスト吸入器 | |
JP5368661B1 (ja) | ガスミスト吸入器 | |
JP5419236B2 (ja) | ガスミストマスク装置 | |
JP3163836U (ja) | ガスミスト圧浴用ボックス | |
JP2020124354A (ja) | ガスミスト発生装置 | |
JP2020124353A (ja) | ガスミスト発生装置 | |
CN221491076U (zh) | 一种新型上药器 | |
CN202875995U (zh) | 新型雾化吸入器 | |
JP2020124355A (ja) | ガスミスト発生装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140306 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150814 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150909 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151106 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160216 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160223 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5892933 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |